Reengineering Methadone Treatment Study of Patient-centered Methadone Treatment
Information source: Friends Research Institute, Inc.
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Opiate Dependence
Intervention: Patient-Centered Methadone Treatment (Other); Methadone Treatment as usual (Other)
Phase: Phase 3
Status: Active, not recruiting
Sponsored by: Friends Research Institute, Inc. Official(s) and/or principal investigator(s):
Robert P Schwartz, M.D., Principal Investigator, Affiliation: Friends Research Institute, Inc.
Summary
The purpose of the study is to determine whether a change in the rules and staff roles in
methadone treatment programs will result in greater lengths of stay in treatment and lower
rates of heroin and cocaine use, crime and HIV-risk behavior as compared to methadone
treatment as usual.
Clinical Details
Official title: Reengineering Methadone Treatment: A Randomized Clinical Trial
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Primary outcome: Urine test for opiates
Secondary outcome: Urine cocaine drug testHIV risk behavior Criminal behavior Quality of Life Opiate dependence Cocaine dependence
Detailed description:
Early drop-out and premature discharge from methadone treatment is common in the United
States and may be associated with drug use and its associated problems. The purpose of this
study is to evaluate the effectiveness of a novel approach to the organization methadone
treatment in which the patient rules and staff roles of the clinic will be modified for
study participants as compared to patients receiving standard methadone treatment.
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- opiate dependence
- newly admitted to methadone treatment
Exclusion Criteria:
- pregnancy
Locations and Contacts
Institutes for Behavior Resources REACH, Baltimore, Maryland 21218, United States
University of Maryland Drug Treatment Center, Baltimore, Maryland 21223, United States
Additional Information
Starting date: September 2011
Last updated: March 5, 2015
|
